A new system can dial expression of synthetic genes up or down
The promoter editing system could be used to fine-tune gene therapy or to more efficiently reprogram cells for therapeutic use.
The promoter editing system could be used to fine-tune gene therapy or to more efficiently reprogram cells for therapeutic use.
MIT researchers now hope to develop synthetic versions of these molecules, which could be used to treat or prevent foodborne illnesses.
Cache DNA has developed technologies that can preserve biomolecules at room temperature to make storing and transporting samples less expensive and more reliable.
Advance from SMART will help to better identify disease markers and develop targeted therapies and personalized treatment for diseases such as cancer and antibiotic-resistant infection.
The findings may redefine how cell identity is established and enable the creation of more sophisticated engineered tissues.
A new approach can reveal the features AI models use to predict proteins that might make good drug or vaccine targets.
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
MIT spinout Tissium recently secured FDA marketing authorization of a biopolymer platform for nerve repair.
Combining powerful imaging, perturbational screening, and machine learning, researchers uncover new human host factors that alter Ebola’s ability to infect.
The Fairbairn Menstruation Science Fund will allow researchers to accelerate the understanding and treatment of often-neglected diseases that tend to be more common in women.
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
The molecules trigger a built-in cellular stress response and show promise as broad-spectrum antivirals against Zika, herpes, RSV, and more.
Launched with a gift from the Biswas Family Foundation, the Biswas Postdoctoral Fellowship Program will support postdocs in health and life sciences.
Gitanjali Rao, a rising junior majoring in biological engineering, received the prestigious award created by the late theoretical physicist, cosmologist, and author.
The MIT-MGB Seed Program, launched with support from Analog Devices Inc., will fund joint research projects that advance technology and clinical research.